A rapid, topographical platelet activation assay.

Platelets are central in maintaining normal haemostasis and are responsible for the cessation of blood loss following vascular injury. Platelet adhesion, leading to thrombus formation, involves rapid and distinct morphological changes culminating in cell aggregation. Rapid and highly specific platelet diagnostic tests are currently being developed to enable monitoring of drug response in patients with cardiovascular diseases. For a diagnostic device to be effective it needs to be rapid and simple, requiring minimal user interaction and providing results with minimal delay. This study describes the development of a rapid, label free platform for assay platelet function and demonstrates its use to monitor the influence of anti-thrombotic drugs. A rapid, single-step cell purification surface immobilises platelets from whole blood onto a protein array at specific locations used to define the assay site. Morphological changes and cell aggregation properties of activated platelets are exploited and combined within a label free, rapid, dye displacement chamber to determine cell morphology. Stimulation-dependent changes in cell morphology are described using both high resolution AFM imaging and a dye displacement platform.

[1]  M. Radmacher,et al.  From molecules to cells: imaging soft samples with the atomic force microscope. , 1992, Science.

[2]  Ivo F Sbalzarini,et al.  Dynamic measurement of the height and volume of migrating cells by a novel fluorescence microscopy technique. , 2011, Lab on a chip.

[3]  R. Marchant,et al.  Intermolecular force mapping of platelet surfaces on collagen substrata. , 1999, Journal of biomedical materials research.

[4]  K. Mahaffey,et al.  Promises of PAR-1 Inhibition in Acute Coronary Syndrome , 2012, Current Cardiology Reports.

[5]  A. Michelson.  Methods for the measurement of platelet function. , 2009, The American journal of cardiology.

[6]  M. Hollenberg,et al.  Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. , 1999, The Journal of pharmacology and experimental therapeutics.

[7]  P. Nurden,et al.  Advances in our understanding of the molecular basis of disorders of platelet function , 2011, Journal of thrombosis and haemostasis : JTH.

[8]  Tanmay Bera,et al.  Characterization of antiplatelet properties of silver nanoparticles. , 2009, ACS nano.

[9]  R. Marchant,et al.  Force measurements on platelet surfaces with high spatial resolution under physiological conditions. , 2000, Colloids and surfaces. B, Biointerfaces.

[10]  Mark D. Huffman,et al.  Novel treatments for cardiovascular disease prevention. , 2012, Cardiovascular therapeutics.

[11]  Seung‐Jung Park,et al.  A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. , 2011, Journal of the American College of Cardiology.

[12]  R. Albrecht,et al.  Redistribution of the fibrinogen receptor of human platelets after surface activation , 1984, The Journal of cell biology.

[13]  N. Kieffer,et al.  Fibrinogen and glycoprotein IIb/IIIa localization during platelet adhesion. Localization to the granulomere and at sites of platelet interaction. , 1990, The American journal of pathology.

[14]  V. Hlady,et al.  Using microcontact printing of fibrinogen to control surface-induced platelet adhesion and activation. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[15]  Anjan Kr Dasgupta,et al.  Multistability in platelets and their response to gold nanoparticles. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[16]  D. Atar,et al.  Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. , 2007, Thrombosis research.

[17]  Kenichi A Tanaka,et al.  Blood Coagulation: Hemostasis and Thrombin Regulation , 2009, Anesthesia and analgesia.

[18]  Lang Tran,et al.  Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  M. Hilchenbach,et al.  THE USE OF FLUORESCENT PROBES IN IMMUNOCHEMISTRY * , 1990, Photochemistry and photobiology.

[20]  T. Edgington,et al.  Human Platelets Possess an Inducible and Saturable Receptor Specific for Fibrinogen , 1979, Thrombosis and Haemostasis.

[21]  A J Ricco,et al.  Single-step separation of platelets from whole blood coupled with digital quantification by interfacial platelet cytometry (iPC). , 2010, Langmuir : the ACS journal of surfaces and colloids.